Charles Weijer
Charles Weijer
Professor of Medicine, Epidemiology & Biostatistics, and Philosophy, Western University
Verified email at - Homepage
Cited by
Cited by
Requirements for ethics committee review for studies submitted to Implementation Science
MP Eccles, C Weijer, B Mittman
Implementation science 6 (1), 1-3, 2011
Protecting communities in biomedical research
C Weijer, EJ Emanuel
Science 289 (5482), 1142-1144, 2000
Informing study participants of research results: an ethical imperative
CV Fernandez, E Kodish, C Weijer
IRB: Ethics & Human Research 25 (3), 12-19, 2003
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
K Hemming, M Taljaard, JE McKenzie, R Hooper, A Copas, JA Thompson, ...
bmj 363, 2018
Protecting communities in research: current guidelines and limits of extrapolation
C Weijer, G Goldsand, EJ Emanuel
Nature genetics 23 (3), 275-280, 1999
The Ottawa statement on the ethical design and conduct of cluster randomized trials
C Weijer, JM Grimshaw, MP Eccles, AD McRae, A White, JC Brehaut, ...
PLoS medicine 9 (11), e1001346, 2012
The ethical analysis of risk
C Weijer
Journal of Law, Medicine & Ethics 28 (4), 344-361, 2000
When are research risks reasonable in relation to anticipated benefits?
C Weijer, PB Miller
Nature medicine 10 (6), 570-573, 2004
Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trialForAgainst
C Weijer, MW Enkin, SH Shapiro, KC Glass
Bmj 321 (7263), 756-758, 2000
Protecting communities in research: philosophical and pragmatic challenges
C Weijer
Cambridge Quarterly of Healthcare Ethics 8 (4), 501-513, 1999
In loco parentis minimal risk as an ethical threshold for research upon children
B Freedman, A Fuks, C Weijer
The Hastings Center Report 23 (2), 13-19, 1993
Placebo orthodoxy in clinical research II: ethical, legal, and regulatory myths
B Freedman, KC Glass, C Weijer
Journal of Law, Medicine & Ethics 24 (3), 252-259, 1996
Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8
NM Ivers, M Taljaard, S Dixon, C Bennett, A McRae, J Taleban, Z Skea, ...
Bmj 343, 2011
How to design efficient cluster randomised trials
K Hemming, S Eldridge, G Forbes, C Weijer, M Taljaard
bmj 358, 2017
Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: the CONSERVE 2021 statement
AM Orkin, PJ Gill, D Ghersi, L Campbell, J Sugarman, R Emsley, PG Steg, ...
Jama 326 (3), 257-265, 2021
Ethical issues posed by cluster randomized trials in health research
C Weijer, JM Grimshaw, M Taljaard, A Binik, R Boruch, JC Brehaut, ...
Trials 12 (1), 1-11, 2011
Rehabilitating equipoise
PB Miller, C Weijer
Kennedy Institute of Ethics Journal 13 (2), 93-118, 2003
Placebo orthodoxy in clinical research I: empirical and methodological myths
B Freedman, C Weijer, KC Glass
Journal of Law, Medicine & Ethics 24 (3), 243-251, 1996
Bioethics for clinicians: 10. Research ethics
C Weijer, B Dickens, EM Meslin
CMAJ 156 (8), 1153-1157, 1997
When is informed consent required in cluster randomized trials in health research?
AD McRae, C Weijer, A Binik, JM Grimshaw, R Boruch, JC Brehaut, ...
Trials 12 (1), 1-13, 2011
The system can't perform the operation now. Try again later.
Articles 1–20